Purchase Order W81K0018P0655
Award Date 10/1/18
Potential Completion Date 9/30/23
Potential Value $7.6M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Roche Diagnostics Corporation was awarded a $2,049,995.92 firm fixed price delivery order against an existing contract vehicle to provide CORE LAB:IMMUNOASSAY TESTING CPRR services for the Department of the Army Medical Command. The delivery order, which has no set-aside designation, will support option year requirements and increased quantities through a period of performance ending September 30, 2023. The location of performance will be in Castleton, Indiana. Roche Diagnostics, doing...
- Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, was awarded a $39,235.49 firm fixed price blanket purchase agreement (BPA) call contract by the Department of the Army Medical Command on September 27, 2023. The contract has an anticipated completion date of October 6, 2023 and calls off of an existing BPA to supply laboratory instruments, reagents, test kits, and associated products and services in support of medical facilities located at Fort Meade, Maryland. As a...
- The Department of the Army Medical Command awarded Roche Diagnostics Corporation a $1.9 million firm fixed price delivery order against an unspecified contract vehicle to provide CORE LAB:IMMUNOASSAY TESTING CPRR services. Roche will deliver immunology laboratory testing and analysis at its facility in Castleton, Indiana through September 2022 in support of the Army Medical Command's medical research and healthcare programs. No subcontractors or set aside designations were identified. This...
- This federal contract was awarded by the Department of the Army Medical Command to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics and associated products and services. The $132,817.68 firm-fixed-price purchase order is for the delivery of ROCHE COBAS products and services. The contract has no set-aside designation and was awarded on October 1, 2019 with a completion date of October 31, 2020. Roche Diagnostics has...
- Roche Diagnostics Corporation was awarded a federal contract on August 14, 2025, by the Defense Health Agency for COBAS Assembly supplies and services. This is a call order under a Blanket Purchase Agreement with a firm fixed-price structure and a ceiling value of $16,080.07. The work will be performed in Castleton, Indiana, with an ultimate completion date of September 30, 2025. This contract award carries no set-aside designation, indicating open competition in the federal marketplace. The...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the supply of ROCHE COBAS products. The contract, valued at $150,371.25, is a firm fixed-price purchase order awarded by the Department of the Army Medical Command. The contract does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit organization that manufactures in vitro diagnostics, reagents, laboratory instruments, and associated products and...
- Roche Diagnostics Corporation was awarded a firm fixed price contract by the Defense Health Agency for $24,781.79 to provide COBAS analyzers for clinical chemistry and immunochemistry testing. The contract has no set-aside designation and performance will occur in Castleton, Indiana, with completion by September 30, 2024. This award was issued under a Blanket Purchase Agreement call, suggesting it draws from an existing indefinite-delivery vehicle between Roche Diagnostics and the Defense Health...
- This federal contract award was made by the Department of the Army Medical Command to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, which was not set aside, is for the provision of immunoassay testing services with a completion date of September 30, 2018 and a potential value of $2,022,067.73. Roche Diagnostics has a history of...
- This firm-fixed-price purchase order was awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Roche Diagnostics Corporation for $134,689.40 to provide laboratory testing supplies. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments, has a long history of serving federal healthcare agencies including the VA, DoD, HHS, USDA, and Commerce through both prime and subcontract awards. The contract has...
- Roche Diagnostics Corporation received a firm fixed-price delivery order award from the Defense Health Agency on October 1, 2023, for reagents valued at $341,575.26, with performance at Fort Leonard Wood, Missouri, concluding March 31, 2025. This delivery order was issued without a set-aside designation and is a child contract under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III), reflecting open competition in the federal marketplace. Roche Diagnostics Corporation, headquartered in...